Vaccination may protect against SARS-CoV-2 infection at the eye surface
Researchers in Australia have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) induces key antibodies at the eye surface that may help to protect against the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). // 5.8.2021
A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination
Vaccines against SARS-CoV-2 administered via the parenteral route (intra-muscular – i.m.) are effective at preventing COVID-19 in part by inducing neutralizing antibodies in the blood.
Researchers in the United States and Canada have conducted a study showing that the vaccines developed by Pfizer-BioNTech and Moderna to protect against coronavirus disease 2019 (COVID-19) generate local antibody responses in the salivary gland that are independent of the systemic immune response.// 5.8.2021
REACT-1 round 13 final report: exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021
Coronavirus (COVID-19) Infection Survey technical article - Office for National Statistics
This analysis provides data about positivity after vaccination from the Coronavirus (COVID-19) Infection Survey. This analysis has been produced in partnership with University of Oxford. // July
Tartunnan riski tippuu radikaalisti 21 päivää ekan rokotuksen jälkeen ja että jos saavat tartunnan on tartunta oireeton tai vähäoireinen ja viruskuorma pienempi
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study
Objectives Highly effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed but variants of concerns (VOCs) with mutations in the spike protein are worrisome, especially B.1.617.2 (Delta) which has rapidly spread across the world. // 31.7.2021
A blood marker predicts who gets ‘breakthrough’...
Nature - Real-world evidence from a medical centre links high levels of potent antibodies after vaccination to a reduced risk of infection. //28.7.2021
COVID-19 vaccines: Are side effects and protection level linked?
In this Snapshot feature, we answer a commonly asked question: If you have not had side effects after a COVID-19 vaccine, are you protected against SARS-CoV-2? // 26.7.2021
Asiantuntija: Laumasuoja menetetty tältä vuodelta, koronaepidemia ei sammu enää millään rajoituksilla – jäljellä on nyt 2 keinoa
Deltamuunnos saattaa vaatia yli 90 prosentin rokotekattavuuden. Rokotetutkimuskeskuksen johtajan Mika Rämetin mukaan siihen ei ole mahdollista päästä tänä vuonna.// 24.7.2021
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
Original Article from The New England Journal of Medicine — Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines //22.7.2021
This is why vaccinated people are still testing positive for COVID-19
The vaccines don't totally stop infection—but even with reports of "breakthrough cases", they still dramatically reduce the risk of serious illness// 22.7.2021
‘I’m sorry, but it’s too late’: Alabama doctor tells unvaccinated, dying COVID patients
“And now all you really see is their fear and their regret. And even though I may walk into the room thinking, ‘Okay, this is your fault, you did this to yourself,’ when I leave the room, I just see a person that's really suffering, and that is so regretful for the choice that they made.” // 21.7.2021